SAN DIEGO--(BUSINESS WIRE)--Oct. 17, 2018--
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and
manufacturer of the only touchscreen insulin pumps with continuous
glucose monitoring integration, plans to release its third quarter 2018
results after the financial markets close on Thursday, November 1, 2018.
The Company will hold a conference call and simultaneous webcast on the
same day at 5:30pm Eastern Time (2:30pm Pacific Time), to discuss its
third quarter 2018 financial and operating results.
Conference Call/Webcast Details:
November 1, 2018
Time:5:30pm Eastern Time (2:30pm
Toll Free Dial-In Number: (855) 427-4396
Dial-In Number: (484) 756-4261
Conference ID: 1782389
An archive of the webcast will be available for 30 days following the
event on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com
in the “Events & Presentations” section.
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. (www.tandemdiabetes.com)
is a medical device company dedicated to improving the lives of people
with diabetes through relentless innovation and revolutionary customer
experience. Tandem takes an innovative, user-centric approach to the
design, development and commercialization of products for people with
diabetes who use insulin. Tandem manufactures and sells the t:slim X2™
Insulin Pump, which features integrated continuous glucose monitoring.
Tandem is based in San Diego, California.
Tandem Diabetes Care is a registered trademark and t:slim X2 is a
trademark of Tandem Diabetes Care, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181017005848/en/
Source: Tandem Diabetes Care, Inc.
Tandem Diabetes Care